NADPH oxidase (Nox2) was found to be essential for angiotensin II–induced cardiac hypertrophy [39], which is involved in the enhanced activation of MAPKs and the NF-κB pathway [12]. Here, NFKB1 is linked to cardiac hypertrophy.